BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17433870)

  • 1. New twists of T cell fate: control of T cell activation and tolerance by TGF-beta and NFAT.
    Sundrud MS; Rao A
    Curr Opin Immunol; 2007 Jun; 19(3):287-93. PubMed ID: 17433870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasticity of CD4+ T cell lineage differentiation.
    Zhou L; Chong MM; Littman DR
    Immunity; 2009 May; 30(5):646-55. PubMed ID: 19464987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoantigens overcome human TCRVgamma9+ gammadelta Cell immunosuppression by TGF-beta: relevance for cancer immunotherapy.
    Capietto AH; Martinet L; Cendron D; Fruchon S; Pont F; Fournié JJ
    J Immunol; 2010 Jun; 184(12):6680-7. PubMed ID: 20483742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the development and effector functions of TH17 cells.
    Ghilardi N; Ouyang W
    Semin Immunol; 2007 Dec; 19(6):383-93. PubMed ID: 18083530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells.
    Wahl SM; Swisher J; McCartney-Francis N; Chen W
    J Leukoc Biol; 2004 Jul; 76(1):15-24. PubMed ID: 14966194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
    Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
    J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1β and TGF-β act antagonistically in induction and differentially in propagation of human proinflammatory precursor CD4+ T cells.
    Hebel K; Rudolph M; Kosak B; Chang HD; Butzmann J; Brunner-Weinzierl MC
    J Immunol; 2011 Dec; 187(11):5627-35. PubMed ID: 22048775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation.
    Annunziato F; Cosmi L; Liotta F; Maggi E; Romagnani S
    Int Immunol; 2008 Nov; 20(11):1361-8. PubMed ID: 18820263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th17 cell differentiation: the long and winding road.
    McGeachy MJ; Cua DJ
    Immunity; 2008 Apr; 28(4):445-53. PubMed ID: 18400187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.
    Acosta-Rodriguez EV; Napolitani G; Lanzavecchia A; Sallusto F
    Nat Immunol; 2007 Sep; 8(9):942-9. PubMed ID: 17676045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lineage and signal strength determine the inhibitory effect of transforming growth factor beta1 (TGF-beta1) on human antigen-specific Th1 and Th2 memory cells.
    Holzer U; Rieck M; Buckner JH
    J Autoimmun; 2006 Jun; 26(4):241-51. PubMed ID: 16730947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional basis of lymphocyte tolerance.
    Borde M; Barrington RA; Heissmeyer V; Carroll MC; Rao A
    Immunol Rev; 2006 Apr; 210():105-19. PubMed ID: 16623767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGFbeta-mediated immunoregulation.
    Peng Y; Gorelik L; Laouar Y; Li MO; Flavell RA
    Ernst Schering Res Found Workshop; 2006; (56):155-60. PubMed ID: 16329651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta as a T cell regulator in colitis and colon cancer.
    Becker C; Fantini MC; Neurath MF
    Cytokine Growth Factor Rev; 2006; 17(1-2):97-106. PubMed ID: 16298544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta as a promising option in the treatment of multiple sclerosis.
    Mirshafiey A; Mohsenzadegan M
    Neuropharmacology; 2009; 56(6-7):929-36. PubMed ID: 19285095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells.
    Fantini MC; Rizzo A; Fina D; Caruso R; Becker C; Neurath MF; Macdonald TT; Pallone F; Monteleone G
    Eur J Immunol; 2007 Nov; 37(11):3155-63. PubMed ID: 17918200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta in T-cell biology.
    Gorelik L; Flavell RA
    Nat Rev Immunol; 2002 Jan; 2(1):46-53. PubMed ID: 11905837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic and combinatorial control of T cell activation and differentiation by transcription factors.
    Sundrud MS; Nolan MA
    Curr Opin Immunol; 2010 Jun; 22(3):286-92. PubMed ID: 20399089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFAT in lymphocytes: a factor for all events?
    Serfling E; Berberich-Siebelt F; Avots A
    Sci STKE; 2007 Aug; 2007(398):pe42. PubMed ID: 17684296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.